与KCNC1相关的渐进性肌性:一个病例报告
Mehri Salari1, Sara Sadeghzadeh2, Masoud Etemadifar3
1Shahid Beheshti University of Medical Sciences Tehran Iran.
Clinical case reports
|August 6, 2025
概括
与KCNC1相关的渐进性肌细胞性 (EPM7) 是一种罕见的遗传性疾病. 基因检测对于诊断这种综合征和探索未来的基因疗法等治疗方法至关重要.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 罕见疾病 罕见疾病
背景情况:
- 渐进性肌性 (EPM7) 是一种罕见的神经疾病.
- 它的特征是发作,肌肉发作和动力衰竭.
- 遗传基础涉及KCNC1基因的突变.
研究的目的:
- 报告伊朗首例与KCNC1相关的EPM7病例.
- 强调基因检测对诊断的重要性.
- 讨论潜在的治疗策略.
主要方法:
- 临床病例的介绍.
- 基因分析 (细节未提供摘要).
主要成果:
- 确定了第一个与KCNC1相关的EPM7的伊朗患者.
- 这一案例强调了基因检测的诊断效用.
结论:
- 基因检测对于诊断与KCNC1相关的EPM7.1至关重要.
- 未来的研究可能将重点放在基因疗法和这种综合征的新药药理治疗上.
相关概念视频
Seizures: Classification
593
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
593
Epilepsy and Seizures: Overview
280
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
280
Antiepileptic Drugs: Potassium Channel Activators
278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
278
Antiepileptic Drugs: Glutamate Antagonists
516
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
516
Antiepileptic Drugs: GABAergic Pathway Potentiators
650
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
650


